Location History:
- N. Robbinsdale, MN (US) (2015)
- Robbinsdale, MN (US) (2015 - 2023)
Company Filing History:
Years Active: 2015-2023
Title: Innovations and Contributions of James D Mendoza
Introduction
James D Mendoza is a notable inventor based in Robbinsdale, MN (US). He has made significant contributions to the field of assay methods and immune response modifiers. With a total of 5 patents, his work has advanced the understanding and application of various biochemical processes.
Latest Patents
One of his latest patents is focused on solution phase homogeneous assays. This invention discloses methods, reagents, kits, and systems for determining an analyte in a sample suspected of containing the analyte, where all reagents are soluble in aqueous solution. The assay method includes treating a sample under specific conditions to activate a chemiluminescent compound if the analyte is present. Additionally, the sample is treated with an agent to reduce unrelated signals, followed by the application of a trigger solution to produce light from the activated compound. Importantly, no reagents are associated with a surface or solid phase. Another significant patent involves immune response modifier conjugates, which includes an IRM moiety and a second active moiety covalently linked to the IRM moiety without relying on UV irradiation.
Career Highlights
Throughout his career, James D Mendoza has worked with prominent companies such as Beckman Coulter, Inc. and 3M Innovative Properties Company. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of biochemistry.
Collaborations
James has collaborated with notable individuals in his field, including Hashem Akhavan-Tafti and Dean G Binger. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
James D Mendoza's contributions to the field of assay methods and immune response modifiers highlight his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a commitment to improving analytical techniques and therapeutic applications.